A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis
Abstract An increased incidence of narcolepsy type 1 (NT1) was observed in Scandinavia following the 2009–2010 influenza Pandemrix vaccination. The association between NT1 and HLA-DQB1*06:02:01 supported the view of the vaccine as an etiological agent. A/H1N1 hemagglutinin (HA) is the main antigenic...
Main Authors: | Alexander Lind, Ilaria Marzinotto, Cristina Brigatti, Anita Ramelius, Lorenzo Piemonti, Vito Lampasona |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83543-z |
Similar Items
-
Intrinsic factor autoantibodies by luminescent immuno-precipitation system in patients with corpus atrophic gastritis
by: Ilaria Marzinotto, et al.
Published: (2021-01-01) -
COVID-19 in Solid Organ Transplant Recipient: Exploring Cumulative Incidence, Seroprevalence and Risk Factors for Disease Severity
by: Rossana Caldara, et al.
Published: (2021-12-01) -
Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test
by: Madeleine Wallenius, et al.
Published: (2019-05-01) -
Screening for antibodies in narcolepsy type 1 and type 2
by: Giannoccaro, M, et al.
Published: (2017) -
Pre-Existing Diabetes and COVID-Associated Hyperglycaemia in Patients with COVID-19 Pneumonia
by: Andrea Laurenzi, et al.
Published: (2021-08-01)